We are live on ! Find out more
SRPT icon

Sarepta Therapeutics
SRPT

177 hedge funds and large institutions have $1.08B invested in Sarepta Therapeutics in 2016 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 63 increasing their positions, 54 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

72.29% more ownership

Funds ownership: 0% → 72.29% (+72%)

17% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 54

9% more call options, than puts

Call options by funds: $212M | Put options by funds: $195M

5% less funds holding

Funds holding: 186 → 177 (-9)

14% less first-time investments, than exits

New positions opened: 43 | Existing positions closed: 50

58% less capital invested

Capital invested by funds: $2.59B → $1.08B (-$1.51B)

64% less funds holding in top 10

Funds holding in top 10: 11 → 4 (-7)

Holders
177
Holders Change
-9
Holders Change %
-4.84%
% of All Funds
4.42%
Holding in Top 10
4
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-63.64%
% of All Funds
0.1%
New
43
Increased
63
Reduced
54
Closed
50
Calls
$212M
Puts
$195M
Net Calls
+$17.1M
Net Calls Change
+$274M

Top Buyers

1
CC
Carlson Capital
Texas
+$88.5M
2
SM
Sabby Management
Florida
+$59.4M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$27.9M
4
BFA
BlackRock Fund Advisors
California
+$21.6M
5
CCM
Cadian Capital Management
New York
+$14M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$77M
2
Millennium Management
Millennium Management
New York
-$64.8M
3
JG
Jefferies Group
New York
-$59.3M
4
RG
Redmile Group
California
-$39.3M
5
Jennison Associates
Jennison Associates
New York
-$33.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
GT
151
Glenmede Trust
Pennsylvania
$54K -$1.53K -38 -2%
BNP Paribas Financial Markets
152
BNP Paribas Financial Markets
France
$52.2K -$65.7K -1,637 -46%
MFW
153
Mosaic Family Wealth
Missouri
$52K +$12K +300 +19%
PNC Financial Services Group
154
PNC Financial Services Group
Pennsylvania
$51K -$12K -300 -14%
MFS
155
MSI Financial Services
Massachusetts
$48K +$27K +672 +62%
CLOS
156
Compagnie Lombard Odier SCmA
Switzerland
$44K – – –
IA
157
IFP Advisors
Florida
$39K -$26.1K -650 -31%
US Bancorp
158
US Bancorp
Minnesota
$36K +$48.6K +1,209 +1,008%
Zurich Cantonal Bank
159
Zurich Cantonal Bank
Switzerland
$35K – – –
LTFS
160
Ladenburg Thalmann Financial Services
Florida
$33K -$129K -3,200 -73%
FAM
161
Fortaleza Asset Management
Illinois
$33K +$3.62K +90 +8%
NFG
162
Next Financial Group
Texas
$27K – – –
BJ
163
BlackRock Japan
Japan
$22K +$13.3K +330 +72%
NSIM
164
North Star Investment Management
Illinois
$20K – – –
KF
165
Krilogy Financial
Missouri
$18K +$2.01K +50 +8%
Envestnet Asset Management
166
Envestnet Asset Management
Illinois
$16K +$23.1K +575 New
Nisa Investment Advisors
167
Nisa Investment Advisors
Missouri
$16K +$24.1K +600 New
AF
168
Allworth Financial
California
$11K – – –
PSC
169
Prentiss Smith & Co
Vermont
$11K – – –
SFS
170
Sowell Financial Services
Arkansas
$6K +$8.03K +200 New
GWM
171
Geneos Wealth Management
Colorado
$5K -$2.01K -50 -20%
GBBWRPM
172
Genovese Burford & Brothers Wealth & Retirement Plan Management
California
$3K +$4.02K +100 New
MWM
173
MinichMacGregor Wealth Management
New York
$1K – – –
PCA
174
Peddock Capital Advisors
Massachusetts
$1K – – –
RAM
175
Riggs Asset Management
Pennsylvania
$1K – – –
5 6
7
8 9

SRPT Hedge Fund Activity: Q4 2016 in Review

177 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q4 2016, worth a combined $1.08B — down 58% from $2.59B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of SRPT and 43 opened new positions — a net loss of 7 holders — while 54 trimmed existing stakes and 63 added.

The largest buyer was Carlson Capital, opening a new position worth an estimated $88.5M. The largest seller was Point72 Asset Management, cutting an estimated $77M.

  • 177 institutional investors held Sarepta Therapeutics (SRPT) as of Q4 2016, down from 186 in Q3 2016.
  • Funds reported $1.08B of Sarepta Therapeutics stock for Q4 2016, down 58% quarter-over-quarter.
  • 43 funds opened new Sarepta Therapeutics positions in Q4 2016 and 50 closed out, a net change of -7 holders.
  • The largest Sarepta Therapeutics buyer in Q4 2016 was Carlson Capital, an estimated $88.5M added.
  • The largest Sarepta Therapeutics seller in Q4 2016 was Point72 Asset Management, an estimated $77M sold.

Based on aggregated 13F filings for Q4 2016.